Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TOST vs GSK✓SelectedUSD · GSKTOST vs GSK performance historyLatest closeAs of+3.46%11/13
Stock and ETF performance explorer

TOST vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-44.5%
GSK return
+58.8%
Excess return
-103.3%
Maximum drawdown
-80.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.5%+0.5%+2.9%+3.4%
7D0.0%+1.1%-1.1%-0.2%
30D+16.2%+6.3%+9.8%+14.8%
3M-1.5%+1.8%-3.3%-1.9%
6M+55.3%+1.7%+53.7%+54.4%
YTD-2.3%+6.5%-8.9%-4.6%
1Y-5.5%+9.5%-15.0%-8.3%
3Y+151.1%+65.3%+85.8%+112.4%
5Y-27.9%+43.7%-71.7%-41.3%
All-44.5%+58.8%-103.3%-59.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling